BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22404106)

  • 1. Correlation of TSH with the risk of paediatric thyroid carcinoma.
    Chiu HK; Sanda S; Fechner PY; Pihoker C
    Clin Endocrinol (Oxf); 2012 Aug; 77(2):316-22. PubMed ID: 22404106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between the serum TSH concentration and thyroid cancer incidence].
    Li JZ; Jin YJ; Liu X; Zhang LY
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
    Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
    Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
    J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
    Zafón C; Obiols G; Mesa J
    Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
    Jonklaas J; Nsouli-Maktabi H; Soldin SJ
    Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher TSH level is a risk factor for differentiated thyroid cancer.
    Kim HK; Yoon JH; Kim SJ; Cho JS; Kweon SS; Kang HC
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):472-7. PubMed ID: 22924613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyrotropin concentration in children with isolated thyroid nodules.
    Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
    J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thyrotropin suppression in patients with differentiated thyroid carcinoma.
    Deasy J; Prichard RS; Evoy D; McDermott EW
    Ir Med J; 2010; 103(7):202-5. PubMed ID: 20845598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
    Jin J; Machekano R; McHenry CR
    Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elevated level of TSH might be predictive of differentiated thyroid cancer.
    Dorange A; Triau S; Mucci-Hennekinne S; Bizon A; Laboureau-Soares S; Illouz F; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2011 Dec; 72(6):513-21. PubMed ID: 22115282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
    Moon SS; Lee YS; Lee IK; Kim JG
    Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH levels are associated with increased risk of thyroid carcinoma in patients with nodular disease.
    Fighera TM; Perez CL; Faris N; Scarabotto PC; da Silva TT; Cavalcanti TC; Mesa Junior CO; Miasaki F; da Paz Filho GJ; de Carvalho GA
    Endokrynol Pol; 2015; 66(6):480-5. PubMed ID: 26662646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothyroidism following hemithyroidectomy: a retrospective review.
    Su SY; Grodski S; Serpell JW
    Ann Surg; 2009 Dec; 250(6):991-4. PubMed ID: 19779329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between preoperative serum thyroid-stimulating hormone level and nonfunctioning malignant nodule thyroid disease].
    Zeng Q; Liu J; Zhu J; Hu G
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1931-3. PubMed ID: 25895308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
    Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
    Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research of relationship between thyroid-stimulating hormone level after surgery and hypercholesterolemia in female patients with differentiated thyroid cancer].
    Zhang B; Geng L; Lin H; Jia Q; Li T
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 34(6):554-557. PubMed ID: 32842190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.